New tool could better predict duodenal cancer in FAP patients
NCT ID NCT07199127
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to create a more accurate way to predict duodenal cancer risk in people with familial adenomatous polyposis (FAP), a genetic condition that greatly increases the chance of developing this cancer. Researchers will analyze endoscopy images from 300 participants to develop and test new risk models. The goal is to improve early detection and guide better surveillance or treatment decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMPULLA OF VATER ADENOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione IRCCS Istituto Nazionale dei Tumori
RECRUITINGMilan, 20133, Italy
-
IRCCS Ospedale San Raffaele
RECRUITINGMilan, MI, 20129, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a freezing balloon zap away precancerous gut growths?
- Can two targeted drugs boost chemo against a rare Bile-Duct cancer?
- Study checks if stopping a drug made polyps grow faster
- Gut bacteria may influence polyp risk in inherited colon condition
- New biopsy technique may spot hidden abdominal cancers without major surgery
- Could a common drug curb polyps in teens with rare genetic condition?